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Background: Intensity modulated radiotherapy for head and neck cancer necessitates accurate definition of organs
at risk (OAR) and clinical target volumes (CTV). This crucial step is time consuming and prone to inter- and
intra-observer variations. Automatic segmentation by atlas deformable registration may help to reduce time and
variations. We aim to test a new commercial atlas algorithm for automatic segmentation of OAR and CTV in both
ideal and clinical conditions.
Methods: The updated Brainlab automatic head and neck atlas segmentation was tested on 20 patients: 10
cN0-stages (ideal population) and 10 unselected N-stages (clinical population). Following manual delineation of
OAR and CTV, automatic segmentation of the same set of structures was performed and afterwards manually
corrected. Dice Similarity Coefficient (DSC), Average Surface Distance (ASD) and Maximal Surface Distance (MSD)
were calculated for “manual to automatic” and “manual to corrected” volumes comparisons.
Results: In both groups, automatic segmentation saved about 40% of the corresponding manual segmentation
time. This effect was more pronounced for OAR than for CTV. The edition of the automatically obtained contours
significantly improved DSC, ASD and MSD. Large distortions of normal anatomy or lack of iodine contrast were the
limiting factors.
Conclusions: The updated Brainlab atlas-based automatic segmentation tool for head and neck Cancer patients is
timesaving but still necessitates review and corrections by an expert.
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Over the past fifteen years, head and neck cancer (HNC)
radiotherapy treatment has quickly shifted from classical
two-dimensional (2D) radiotherapy to Intensity Modu-
lated Radiotherapy (IMRT), resulting in better Organs at
Risk (OAR) sparing and quality of life preservation [1].
IMRT planning intrinsically produces steep dose gradi-
ents, particularly at the border between target volumes
(TV) and OAR. Control of patients’ immobilization and
accurate volume definition of 3D images are of the ut-
most importance to ensure the improved therapeutic ra-
tio of this technique. The segmentation of the various* Correspondence: jeanfrancois.daisne@cmsenamur.be
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distribution, and reproduction in any mediumOAR is performed according to the anatomical know-
ledge. Gross Tumour Volume (GTV) is defined by ana-
tomical modifications at clinical examination and on
various imaging modalities. Prophylactic Clinical Target
Volume (CTV) is selected and delineated according to
universally accepted guidelines [2,3].
A tedious delineation is time-consuming, particularly
in the complex head and neck region, where complete
segmentation times of up to 180 minutes are reported,
in contrast with the mere 20 minutes needed to create a
simple 2D plan [4]. Delineation is also prone to large
inter-observer variations for both OAR and CTV. In
blind tests, parotids delineation on Computed Tomog-
raphy (CT) or Magnetic Resonance Imaging (MRI) scans
in 20 consecutive patients by three HNC radiation on-
cologists generated significant inter-observer variationsd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of the imaging modality [5]. In an international study on
inter-clinician variability and its dosimetric impact, 32
different centers delineated the most common OAR on
only one HNC patient CT set: brain, spinal cord, brain-
stem, both parotids and mandible. Significant variations
were found for brainstem, both parotids and surprisingly
spinal cord. After planning, this difference translated
into significant variations in the irradiation of the so-
called “reference segmentation”. There were differences
reported of up to about 50% of the parotids Dmean and
more than 20% of the brainstem Dmax [6]. In another
monocenter study, 5 HNC experts performed a thor-
ough qualitative analysis of the inter-observer variability
after delineation of various OAR on 6 different CT sets.
Despite the use of accepted delineation guidelines for
both parotid and submandibular glands [7], significant
differences persisted for mean volumes and concordance
index. Geometrically, the largest differences (up to
3 mm) more often affected cranial and medial limits [8].
Finally, a multicenter survey providing a predefined
GTV on the CT set of a given patient to 20 different
HNC experts highlighted major differences in the CTV
selection and delineation, dose prescription, chemother-
apy prescription and Planning Target Volume (PTV)
margin expansion [9]. The most striking finding was
that, despite the common use of the international guide-
lines [2,3], neck node levels selection and delineation
gave rise to large inter-observer variations of the low
risk CTV volume (mean +/− SD = 205 +/− 123 cc). This
is of particular concern since the compliance to radio-
therapy guidelines is a documented prognostic factor for
HNC treatments [10].
The concept of atlas-based automatic segmentation is
appealing since it could help save significant delinea-
tion time while potentially reducing the inherent inter-
observer variability. Different deformation registration
strategies were developed, based on either individual pa-
tient data, averaged patient generation, multiple patient
data [11] or, more recently, introduction of a volume
post-processing by recognition of the key anatomical
structures of the head and neck area [12,13].
An updated version of the automatic head and neck
atlas was developed for an upcoming Brainlab treatment
planning solution (Brainlab AG, Munich, Germany). It is
based on the deformation registration of an atlas patient
followed by active post-processing. The aim of the
current study is to validate both time gain and accuracy
of this software for the various OAR and CTVs that we
use in clinical practice for unoperated HNC patients in
two subpopulations: one “ideal” population (i.e. without
any pathological node on at least one hemi-neck) and
another “clinical” population (i.e. with a true clinical pre-
scription according to the real N-status).Methods
Patients and volumes selection
Two groups of un-operated HNC patients were de-
fined, all referred to our Radiotherapy Department for
definitive radiotherapy with or without concomitant
chemotherapy. All patients were simulated head first
supine with their head blocked by an anatomical neck
cushion and an individual five-pin thermoplastic mask
(Civco, The Netherlands). Without contra-indication,
iodine contrast was injected in two phases: first 45 cc
at 1.5 cc/sec, then after a rest of 120 sec by 40 cc
at 2.0 cc/sec. CT acquisition started directly after
the end of the second phase with a GE Lightspeed RT
CT-scanner (General Electrics Healthcare, France);
2.5 mm thick slices were reconstructed from the
upper orbita down to the lower part of the clavicula.
Before processing, all data were imported into the
Brainlab treatment planning software (iPlan RT 5.0
Beta, Brainlab AG, Germany) and anonymized with a
number.
– Group A. Ten patients (numbers 1 to 10) with at least
one hemi-neck showing no pathological node (cN0).
These patients were retrospectively selected from our
database to test the algorithm without the interference
of pathological nodes introducing a variation in the
normal anatomy. All but one received iodine contrast
injection. OAR selection was voluntarily restricted to
spinal cord (SC), brainstem (BS) and homolateral
parotid gland (PG). All possible neck node levels were
individually selected in the cN0 hemi-neck: 1a, 1b, 2,
3, 4, 5, 6, retrostyloid (RST), retropharyngeal (RP) and
retroclavicular (RCL).
– Group B. Ten patients (numbers 11 to 20) with various
N-stages to test the algorithm in real clinical
conditions. To avoid any selection bias, these patients
were the 10 first patients of another prospective study
on adaptive radiotherapy (approved by the Ethics
Committee of Clinique and Maternité Ste-Elisabeth on
28 September 2011 with National Belgian Reference
Number B166201112118) proposed to patients on a
consecutive scheme (i.e. without any other selection
criteria than definitive radiotherapy and informed
consent). All but one received iodine contrast
injection. OAR were selected according to our
clinical protocol: SC, BS, both PG, mandibula (M)
and submandibular glands (SMG) only if level Ib
was excluded from CTV. CTV selection (Additional
file 1: Table S1) was clinically based on the one
hand on primary tumor location and extension and
on the other hand on N-stage, strictly according to
the international guidelines [2,3]. All selected levels
were fused together to form a unique “CTV 50 Gy”
object for each patient.
Daisne and Blumhofer Radiation Oncology 2013, 8:154 Page 3 of 11
http://www.ro-journal.com/content/8/1/154Atlas definition and registration algorithm
The reference atlas is built on the CT of a patient in stan-
dard position (head first supine with thermoplastic mask)
with iodine contrast injection, from the vertex down to the
6th thoracic vertebra. OAR and CTV nodal levels are indi-
vidually segmented left and right. OAR list is extensive,
regrouping bones (vertebrae, hyoid, clavicula), cartilages
(cricoid, thyroid), muscles (sterno-cleido-mastoid), glands
(PG, SMG, thyroid) and nervous structures (SC, BS, eyes,
optic nerves, chiasm). Available nodal CTV levels are
those described in the guidelines: 1a, 1b to 6, RST, RP and
RCL. An independent expert who never worked with the
first author performed all segmentations.
Our approach entails a fully automatic segmentation
algorithm using the most common atlas-based registra-
tion technique with various standard and model based
support algorithms (Figure 1). It consists of two main
parts. The first step is a standard atlas-based registration
on CT data sets using intensity difference as similarity
measure and starts with several rigid registrations.
Standard elastic fusion algorithms often fail in matching
the neck region due to the different relative orientations
and positions between head and thorax and the curva-
ture of the spine. The current elastic fusion algorithm is
therefore restricted to preserve reasonable distances be-
tween the vertebras by transferring vertebra reference
points from the atlas to the patient. The distances be-
tween these points are corrected to anatomically correct
values by shifting the deformation vectors, which leads
to a reliable stabilization of the neck region. Elastic fu-
sion and stabilization are done in alternating order. Atlas
registration is in any case a useful start point for seg-
mentation and often already presents the correct point-
to-point correspondence between atlas and patient data
set. Since the neck region is of high variability a second
post-processing step is necessary for segmentation. Fur-
thermore a simple deformation and transfer of the atlas
objects into the patient data set would break the
Grégoire rules by violating plane-conservation [2,3]. The
post-processing task of the current algorithm must
therefore meet the high variability of the neck as well as
the outlining guidelines. The lymph system of both sides
is defined in the atlas as masks surrounding the actual
lymph levels. The muscles and cartilages of the neck re-
gion are masks as well. All these masks are transferred
to the patient and step by step post-processed using typ-
ical Hounsfield values and morphological operations to
smooth the structures. First, thyroid gland and cartilages
are segmented. Together with the bone reference points
and the muscles they define the borders of the lymph
levels, which are cut according to the delineation rules
and define the final structures. It is implemented with
standard image processing techniques based on typical
Hounsfield values, size and shape of the neck structures.Alternating segmentation and reference point detection
on bones, cartilages, muscles and lymph levels are gener-
ating the final structures.
Segmentation
First author performed all segmentations. Reference seg-
mentation was first performed manually (MAN vol-
umes) and slice-by-slice for each patient. A few days
later, MAN volumes were blinded and atlas-based auto-
matic segmentation was applied (AUTO volumes). Last,
AUTO volumes corrected if necessary (CORR volumes).
Comparison pairs, metrics and statistics
Generated volumes were compared to each other in two
ways. The first one was a comparison between AUTO
and MAN volumes to measure the accuracy of the atlas-
based segmentation. Secondly, a comparison between
CORR and MAN volumes allowed measuring both the
time needed to improve AUTO volumes and the intra-
observer variability.
The human time needed to perform manual segmenta-
tion and necessary corrections was recorded in minutes,
as well as the computer time to generate AUTO volumes.
Dice Similarity Coefficient (DSC) and average and
maximal surface distances (ASD and MSD, respectively)
were used for comparisons. DSC is a statistical param-
eter investigating the intersection volume of two objects
by normalizing the intersection volume to a value be-
tween 0 (no overlap) and 1 (perfect overlap) and is de-
fined as DSCA,B = (2 |A ∩ B|) / (|A| + |B|) [14]. ASD and
MSD are geometrical parameters expressed in millimetres
[15,16], smaller distances reflect a better overlap.
Statistical analyses of the paired comparisons were
performed using a double-sided T-test in Excel for Mac
2008 (Microsoft, Richmond, USA) with level of signifi-
cance set at 0.05.
Results
Ideal conditions: group A
For the “ideal” patients in group A (Additional file 2:
Table S2), delineating the OAR and nodal levels one by
one took on average 44.9 min, three quarter of this time
being devoted to the nodal levels. The use of the atlas
led to necessary corrections that on average took
28.5 min, representing a time gain of 37% (P < 0.05).
This gain was relatively larger for OAR (4.5 instead of
11.2 min, - 60%) than for nodal levels (24.0 instead of
33.7 min, - 29%). Of note, CORR time was equivalent to
MAN time for levels 1a, 1b, 4, RP and RST.
Except for spinal cord, which showed minor deviations
needing no further correction, AUTO volumes systemat-
ically needed some improvements, which are reflected
by the better DSC, ASD and MSD parameters after cor-
rection (P < 0.05) (Figure 2). Levels 2, 3, 5, 6, RCL and
Figure 1 Analytical diagram describing the workflow of the automatic segmentation algorithm. SCM : sternocleidomastoid muscle.
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Figure 2 Mean DSC, ASD and MSD in group A for automatic (AUTO) and corrected (CORR) volumes, both compared to manual (MAN)
segmentation. Vertical black line separates OAR section from CTV, and CTV from global mean (TOTAL). Last column of each section refers to mean
values ("subtotal") for OAR and CTV. SC data were excluded since no correction was necessary. RP: retropharyngeal; RST: retrostyloid; RCL: retroclavicular.
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the large time gain for these volumes (Additional file 2:
Table S2). As previously described, corrections for the
other levels required more time. Level 1a is such a tiny
volume that correcting even small deviations took asmuch time as drawing from scratch. For level 1b, most of
the corrections were required at the cranial end, where
the SMG is closely surrounded by muscles, making its dif-
ferentiation difficult for the human eye as well as for the
computer algorithm. Level 4 showed a systematic tendency
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Figure 4e), which consumed most of the correction time.
For RP level, the algorithm showed difficulties to find
the thin fatty layer anterior to the prevertebral muscle
(Figure 3c). Most of the time, this level was wrongly lo-
cated in the muscle itself, i.e. two to three millimetres pos-
teriorly. The algorithm also tended to include the internal
carotid artery laterally. Since this anatomical landmark in-
timately relates to RP and RST levels, correcting the lateral
side of RP level automatically led to a necessary correction
of the medial side of the RST level, explaining the large cor-
rection time needed for this last level. Lastly, it must be no-
ticed that ASD and MSD were not improved by correcting
the RCL level, reflecting its poorly defined anatomical
boundaries and the inherent intra-observer variability.
Clinical conditions: group B
On average, correction time after automatic segmenta-
tion was significantly shorter than manual segmentation
(19.7 vs 34.5 min, P < 0.05). Like for group A, most ofFigure 3 Selected CT slices of patient 16 (N3-stage) with automatic (y
anatomy distortions on the left side of the patient fool the algorithm that
depicted in the different panels: a = RS and RP left; b = 2 bilaterally, 1b anthe gain was obtained for OAR (6.3 vs 16.4 min, P <
0.05). Again, SC did not need any correction, neither M
except in one patient with teeth filling artefacts. Regard-
ing the CTV, results are mixed, with patient 13 requir-
ing an additional 2 min correction time, while 13 min
were gained for patient 14. The average time gain for all
patients in this series was 4.7 min. No significant time
gain was observed for patients 13 (no iodine contrast in-
jection), 16 (large N3) and 17 (large N2a) who demon-
strated large anatomical deviations compared to the
atlas (Figure 3). On the contrary, patients with few ana-
tomic deviations were easy to correct since AUTO seg-
mentation was fairly good (Figure 4). Again, statistically
significant DSC, ASD and MSD parameters improve-
ments were observed after correction of the automatic-
ally generated volumes (Figure 5). It underlines the
necessary human supervision of the obtained result. It
must be noted that SC and M structures were excluded
from analysis since they practically did not need
corrections.ellow lines) and manual (blue lines) segmentations. Large normal
generates inaccurate automatic segmentation (images c, d, e). Levels
d RP; c and d = 3 bilaterally; e = 4 bilaterally; f = RCL left.
Figure 4 Selected CT slices of patient 12 (N0-stage) with automatic (yellow lines) and manual (blue lines) segmentations. Levels
depicted bilaterally in the different panels: a= 2; b and c = 1b and 2; d = 3; e = 4.
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Two different strategies were explored. In group A, auto-
matic segmentation was performed through the iPlan® Net
server (Brainlab AG, Germany). Time ranged from 25 to
50 sec, with an average of 39 sec. In group B, automatic
segmentation was performed on a standalone workstation.
For this group, time ranged from 90 to 155 sec, with an
average of 116.5 sec.
Discussion
The present study demonstrates the advantages and lim-
itations of an automatic segmentation tool for OAR and
nodal CTV to help radiation oncologists in their daily
work, presently for the HNC treatments. It clearly helps
saving time, particularly for the tedious OAR segmentation.We found a steady 40% reduction in both groups, inde-
pendently of the number of delineated OAR. Though
remaining significant, time gain was less prominent for
the nodal CTVs, mainly because of individual anatom-
ical variations. In the group without pathological node
(group A), we could test the algorithm in ideal condi-
tions and determine its limitations level by level. Some
levels were easy to segment automatically and hence,
needed very few corrections. This was particularly true
for levels 2, 3, 5 and 6. On the other hand, levels 1a, 1b,
RS and RP anatomical borders were more difficult to be
determined automatically, mainly because of the lack of
spontaneous contrast between the anatomical key struc-
tures (e.g. between the thin retropharyngeal fatty layer
and the prevertebral muscles or between the summit of
Figure 5 Mean DSC, ASD and MSD in group B for automatic (AUTO) and corrected (CORR) volumes, both compared to manual
segmentation. OAR are grouped together (SC and M excluded).
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systematic inclusion of the scalenus muscles posteriorly
relates to the lymph nodes mask that is voluntarily en-
larged to take account of the matching uncertainties of
the atlas. A tighter mask in this region could help solvethe problem. Last, RCL level suffers large interpreta-
tions of its anatomical boundaries definition, resulting
into large intra-observer variations, though delineation
time can be saved. The study in true clinical conditions
without patient recruitment bias (group B) also shed
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due to large deformations of normal anatomy or lack of
iodine contrast injection. Finally and as a consequence
of all these limitations, it was clearly demonstrated that -
except for spinal cord and mandibula without teeth
fillings- any automatically obtained volume should always
be checked and corrected where necessary by an expert
before planning.
Automatic segmentation accuracy is highly dependent
on similarity between the underlying atlas and the pa-
tient [11]. Different strategies were recently explored in
HNC patient population. The simplest atlas is based on
an individual patient (IND) who must be chosen with
care to ensure the similarity with the largest patients
population. It is the least accurate strategy, particularly
when dissimilarities arise, particularly in the node levels
[17]. A more elegant way to overcome this limitation is
to enlarge the atlas database by adding multiple patients;
an averaged patient is created from the whole database
and used afterwards as an atlas (AVG) [18-20]. Alterna-
tively, multiple atlases generate multiple segmentations
of the same object which, after combination, generate
a single object (MUL) [17]. Anyway, none of these strat-
egies include the recognition of the key anatomic struc-
tures boundaries that are used by the delineating
physician [2,3]. This may potentially lead to violations of
the cranio-caudal limits on the one hand [17] and to non
compensation of large volumes overestimations on the
other hand [18]. “Active Contour” (AC) or “Active Shape
Modelling” post-processing after averaged atlas deforma-
tion constrains volumes within their anatomic bound-
aries, potentially compensating for these problems
(AVG-AC) [12,13,21]. Our method takes the advantages
of the AC methodology applied to the fast and simple
IND atlas.
The comparison of all these different approaches to
our one is limited by variations in the selected volumes
(OAR only, CTV only or both), methodological differ-
ences and the multiple experts involved. Most groups
reported their results by DSC metric, using the same
methodology of MAN segmentation compared to AUTO,
thus providing a reasonable basis for comparison. For BS,
mean DSC of 0.83, 0.78, 0.58, 0.91 and 0.76 were observed
for IND [17], MUL [15], AVG [19], AVG-AC [13] and our
method, respectively. For PG, values of 0.80, 0.79, 0.67,
0.83 and 0.72 were calculated for the same methods,
respectively. Regarding CTVs, the comparison is even
more difficult since N-stage (most often N0) and selected
levels were quite different from one study to another. Dif-
ferent publications reported mean DSC values of 0.60
(levels 2–4, IND) [17], 0.67 (levels 1–5, MUL) [15], 0.79
(levels 1–6 + RP, AVG) [20], 0.46 (levels 1–6, AVG-AC)
[21], 0.70 (levels 2–4, AVG-AC) [12,13], 0.77 (level 1b,
AVG-AC) [13] and 0.60 (all levels in group A, ourmethod). To improve the comparison validity of our
method, our mean DSC value rises up to 0.69 for levels
1b-4 only. Computation time varied also greatly: from
7 min [17,19] up to 21 min [12]. Our recorded times -less
than 2.5 min on workstation and less than 1.5 min on the
iPlan® Net server- compare favourably and are under the
three minutes practical cut-off [22].
Whatever method used, none produces automatic vol-
umes directly usable for planning. It was nicely demon-
strated with a MUL algorithm applied to nine patients
that significant underdosage is observed in reference PTV
when planning is performed based on a PTV generated
from automatic contours. Underdosage of 11 Gy may be
observed even for very good metrics like DSC= 0.8 and
ASD < 1 mm. Of note, this had no impact on OAR [23].
Corrections improve automatic segmentation both
quantitatively (DSC increases by 0.1 on average [15,20]
and qualitatively, but still take time. In our study, the
time gain was about 40% compared to the manual seg-
mentation time, which is in line with the 26 to 47%
range reported in the literature and being an inverse
function of the expertise of the physician [20,24]. The
time savings hold only true for OAR and prophylactic
CTV delineation, not for GTV and high dose CTV. Of
course, one could argue that summing up the times
needed to delineate all these volumes at once would
result in only a small overall time saving. For us it is
important to save time on tasks of less concern and
use these gained resources for more important chal-
lenges, e.g. reviewing a medical file and delineating a GTV
extension.
Using an atlas may also improve inter- and intra-observer
variability. In a study where five different HNC radiation
oncologists each delineated the CTV for five patients, it
was convincingly demonstrated that the corrected atlas-
based contours showed less inter-observer variability than
manual segmentations. Corrected contours were on average
larger than the manual ones, highlighting the potential bias
induced by automatic contours [20]. The same trend was
also detected for OAR delineation when two different
experts teams on two different populations used two
different strategies. In population 1 with team 1, BS, PG
and M were first segmented manually then segmented
automatically by atlas. In population 2 with team 2,
these OAR were segmented first automatically, then
manually corrected. In population 2, mean volumes
were significantly less different than for population 1.
DSC and specificity were on average 20% better in
population 2 than in population 1 [19]. In our study,
the imperfect matching between corrected volumes and
manual ones reflects the bias induced by the automatic
delineation. However, both volumes gave satisfaction
from visual viewpoint and also reflect the best intra-
observer variability that could be achieved.
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be further studied.
 Inter-observer variability could be checked on our
patients by repeating the study on a blinded
multicentre frame.
 All our patients were unoperated; the algorithm may
be evaluated against a post-operative population, which
has never been tested. However, since anatomy would
even be more deformed than in our population B,
we think that more “intelligent” algorithms should
be developed to overcome this limitation.
 Some more OAR could be included in the atlas
(e.g. swallowing structures) and make the purpose of a
new validation. Anyway, since different guidelines
are available [25-27], one must wait for a global
consensus to avoid potential criticisms about a
chosen method.Conclusion
An updated commercial HNC atlas was validated for
both OAR and prophylactic CTV delineation, proving
its interest as help in daily clinical work. It was clearly
demonstrated as time-saving, even though a physician
should always review generated contours. Potential small
improvements were highlighted, e.g. use of MUL atlas,
improved correction tools or introduction of new OAR
in the atlas (e.g. swallowing structures [25-27]).Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
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